Tagged: access to medicines

Press Release

Governments which have failed to pay their contributions to the Global Fund to Fight AIDS, Malaria and Tuberculosis are guilty of breaking their own promise to extend HIV treatment just months after they made it, Oxfam said today.

Press Release

New Oxfam report: The proliferation of substandard medicines in poor countries is being used by rich countries as an excuse to tighten intellectual property rules, boosting the profits of large pharmaceutical companies while making it harder for poor people to get access to the medicines they need.

Policy Paper
Press Release

World leaders made no real commitments to ensure universal access to prevention, treatment and care for AIDS at this week's International AIDS conference in Vienna.

Press Release

As the next round of Anti-Counterfeiting Trade Agreement negotiations get underway this week, Oxfam has called on the negotiating parties to ensure the Agreement does not erect new barriers that prevent generic medicines from reaching poor countries.

Campaign article
Elba Rivera-Urbina of the W8. Credit: German Antonia Miranda

In March 2010, members of the W8 travelled to Canada and EU member states to bring the voice of their communities to the attention of world leaders.

Press Release

The European Union is contradicting world trade rules by putting the interests of big drug companies before the 2 billion people in the world who cannot access essential medicines, according to a new report issued today by Oxfam International and Health Action International Europe.

Press Release
Antiretrovirals. Oxfam works with partners on minimizing transmission and impacts of HIV&AIDS in rural Angola Credit: Andy Hall/Oxfam

17 Feb – Pharmaceutical giant GlaxoSmithKline should be congratulated for breaking industry ranks and taking a major step toward helping poor people in developing countries to get better access to medicines, says international agency Oxfam. However GSK’s initiative this week is just the beginning.

Syndicate content